BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22770648)

  • 1. A case of opportunistic skin infection with Mycobacterium marinum during adalimumab treatment in a patient with Crohn's disease.
    Kump PK; Högenauer C; Wenzl HH; Petritsch W
    J Crohns Colitis; 2013 Feb; 7(1):e15-8. PubMed ID: 22770648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium marinum infection complicating Crohn's disease, treated with infliximab.
    Fallon JC; Patchett S; Gulmann C; Murphy GM
    Clin Exp Dermatol; 2008 Jan; 33(1):43-5. PubMed ID: 17983451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Mycobacterium avium complex infection during antitumor necrosis factor-α therapy in pediatric Crohn disease.
    Jordan N; Waghmare A; Abi-Ghanem AS; Moon A; Salvatore CM
    J Pediatr Gastroenterol Nutr; 2012 Feb; 54(2):294-6. PubMed ID: 21694635
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycobacterium marinum infection complicated by anti-tumour necrosis factor therapy.
    Ramos JM; García-Sepulcre MF; Rodríguez JC; Padilla S; Gutiérrez F
    J Med Microbiol; 2010 May; 59(Pt 5):617-621. PubMed ID: 20133411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].
    Guyot A; Begon E; Abramowitz L; Landry J; Marinho E; Descamps V; Crickx B
    Ann Dermatol Venereol; 2009 Nov; 136(11):806-10. PubMed ID: 19917434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute coronary syndrome in a Crohn's disease patient treated with adalimumab.
    Petitpain N; Bornert-Keller N; Peyrin-Biroulet L
    J Crohns Colitis; 2013 Oct; 7(9):e396. PubMed ID: 23523265
    [No Abstract]   [Full Text] [Related]  

  • 7. Disseminated Mycobacterium mantenii infection with multiple purulent cutaneous lesions.
    Honda Y; Tanizaki H; Otsuka A; Shirakashi M; Imura Y; Mimori T; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2015 Nov; 95(8):1028-9. PubMed ID: 25881714
    [No Abstract]   [Full Text] [Related]  

  • 8. Sarcoidosis complicating treatment with adalimumab for Crohn's disease.
    McDonnell MJ; Rutherford RM; O'Regan A
    J Crohns Colitis; 2014 Sep; 8(9):1140-1. PubMed ID: 24631310
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
    Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening prior to biological therapy in Crohn's disease: adherence to guidelines and prevalence of infections. Results from a multicentre retrospective study.
    van der Have M; Belderbos TD; Fidder HH; Leenders M; Dijkstra G; Peters CP; Eshuis EJ; Ponsioen CY; Siersema PD; van Oijen MG; Oldenburg B;
    Dig Liver Dis; 2014 Oct; 46(10):881-6. PubMed ID: 25081843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disseminated Mycobacterium marinum Infection With a Destructive Nasal Lesion Mimicking Extranodal NK/T Cell Lymphoma: A Case Report.
    Asakura T; Ishii M; Kikuchi T; Kameyama K; Namkoong H; Nakata N; Sugita K; Tasaka S; Shimizu T; Hoshino Y; Okamoto S; Betsuyaku T; Hasegawa N
    Medicine (Baltimore); 2016 Mar; 95(11):e3131. PubMed ID: 26986167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
    Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycobacterium marinum infection in the setting of antitumor necrosis factor alpha therapy for Crohn's disease.
    Levesque BG; Sandborn WJ
    Inflamm Bowel Dis; 2011 Jun; 17(6):1443-4. PubMed ID: 21560204
    [No Abstract]   [Full Text] [Related]  

  • 14. [Level of adalimumab and its antibody titers define the effectiveness of the biological (anticytokine) therapy in Crohn's disease].
    Lazebnik LB; Sagynbaeva VÉ
    Eksp Klin Gastroenterol; 2013; (7):18-22. PubMed ID: 24772870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barrè syndrome after treatment with human anti-tumor necrosis factorα (adalimumab) in a Crohn's disease patient: case report and literature review.
    Cesarini M; Angelucci E; Foglietta T; Vernia P
    J Crohns Colitis; 2011 Dec; 5(6):619-22. PubMed ID: 22115384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adalimumab for the treatment of pediatric Crohn's disease.
    Nuti F; Fiorino G; Danese S
    Expert Rev Clin Immunol; 2015; 11(9):963-72. PubMed ID: 26211396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab.
    Ferreira J; Grochowsky J; Krakower D; Zuromskis P; Baden R; Cheifetz AS
    Am J Gastroenterol; 2012 Aug; 107(8):1268-9. PubMed ID: 22859009
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium marinum with associated bursitis.
    Saadatmand B; Poulton JK; Kauffman CL
    J Cutan Med Surg; 1999 Apr; 3(4):218-20. PubMed ID: 10366400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe adalimumab-induced thrombocytopenia in a patient with Crohn's disease.
    Casanova MJ; Chaparro M; Martínez S; Vicuña I; Gisbert JP
    J Crohns Colitis; 2012 Dec; 6(10):1034-7. PubMed ID: 22534313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rifampicin-resistant Mycobacterium marinum infection in a newly diagnosed HIV-1 individual.
    Seneviratne K; Herieka E
    Int J STD AIDS; 2013 Jan; 24(1):75-7. PubMed ID: 23512514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.